Helix BioPharma Corp. (TSX:HBP)
Canada · Delayed Price · Currency is CAD 2.100
+0.130 (6.60%)
At close: Mar 3, 2026
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 160.39 million as of March 4, 2026. Its market cap has increased by 189.55% in one year.
Market Cap
160.39M
Enterprise Value
160.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.10
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 160.39M, an increase of 1,609.34%. That is a compound annual growth rate of 9.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 150.46M | -16.88% |
| Dec 31, 2025 | 181.02M | 314.90% |
| Dec 31, 2024 | 43.63M | -4.12% |
| Dec 29, 2023 | 45.50M | 5.81% |
| Dec 30, 2022 | 43.00M | 0.61% |
| Dec 31, 2021 | 42.74M | -36.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 426.12M |
| Satellos Bioscience | 350.86M |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 75.08M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 62.62M |
| MedMira | 48.82M |
| Sernova Biotherapeutics | 47.47M |